Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20823448rdf:typepubmed:Citationlld:pubmed
pubmed-article:20823448lifeskim:mentionsumls-concept:C0012155lld:lifeskim
pubmed-article:20823448lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:20823448lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:20823448lifeskim:mentionsumls-concept:C0815327lld:lifeskim
pubmed-article:20823448lifeskim:mentionsumls-concept:C0599781lld:lifeskim
pubmed-article:20823448lifeskim:mentionsumls-concept:C0009830lld:lifeskim
pubmed-article:20823448lifeskim:mentionsumls-concept:C1550518lld:lifeskim
pubmed-article:20823448lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:20823448pubmed:issue6lld:pubmed
pubmed-article:20823448pubmed:dateCreated2010-11-30lld:pubmed
pubmed-article:20823448pubmed:abstractTextThe objective of this study was to assess the response of a large animal model to high dietary fat and fructose (HFFD). Three different metabolic assessments were performed during 13 wk of feeding an HFFD (n = 10) or chow control (CTR, n = 4) diet: oral glucose tolerance tests (OGTTs; baseline, 4 and 8 wk), hyperinsulinemic-euglycemic clamps (HIEGs; baseline and 10 wk) and hyperinsulinemic-hyperglycemic clamps (HIHGs, 13 wk). The ?AUC for glucose during the OGTTs more than doubled after 4 and 8 wk of HFFD feeding, and the average glucose infusion rate required to maintain euglycemia during the HIEG clamps decreased by ?30% after 10 wk of HFFD feeding. These changes did not occur in the CTR group. The HIHG clamps included experimental periods 1 (P1, 0-90 min) and 2 (P2, 90-180 min). During P1, somatostatin, basal intraportal glucagon, 4 × basal intraportal insulin, and peripheral glucose (to double the hepatic glucose load) were infused; during P2, glucose was also infused intraportally (4.0 mg·kg(-1)·min(-1)). Net hepatic glucose uptake during P1 and P2 was -0.4 ± 0.1 [output] and 0.2 ± 0.8 mg·kg(-1)·min(-1) in the HFFD group, respectively, and 1.8 ± 0.8 and 3.5 ± 1.0 mg·kg(-1)·min(-1) in the CTR group, respectively (P < 0.05 vs. HFFD during P1 and P2). Glycogen synthesis through the direct pathway was 0.5 ± 0.2 and 1.5 ± 0.4 mg·kg(-1)·min(-1) in the HFFD and CTR groups, respectively (P < 0.05 vs. HFFD). In conclusion, chronic consumption of an HFFD diminished the sensitivity of the liver to hormonal and glycemic cues and resulted in a marked impairment in NHGU and glycogen synthesis.lld:pubmed
pubmed-article:20823448pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:languageenglld:pubmed
pubmed-article:20823448pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:citationSubsetIMlld:pubmed
pubmed-article:20823448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20823448pubmed:statusMEDLINElld:pubmed
pubmed-article:20823448pubmed:monthDeclld:pubmed
pubmed-article:20823448pubmed:issn1522-1555lld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:MooreMary...lld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:NealDoss WDWlld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:CherringtonAl...lld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:ScottMelanieMlld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:FarmerBenBlld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:SmithMartaMlld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:WilliamsPhilPlld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:CoateKatie...lld:pubmed
pubmed-article:20823448pubmed:authorpubmed-author:RoopJoshuaJlld:pubmed
pubmed-article:20823448pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20823448pubmed:volume299lld:pubmed
pubmed-article:20823448pubmed:ownerNLMlld:pubmed
pubmed-article:20823448pubmed:authorsCompleteYlld:pubmed
pubmed-article:20823448pubmed:paginationE887-98lld:pubmed
pubmed-article:20823448pubmed:dateRevised2011-2-14lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:meshHeadingpubmed-meshheading:20823448...lld:pubmed
pubmed-article:20823448pubmed:year2010lld:pubmed
pubmed-article:20823448pubmed:articleTitleChronic consumption of a high-fat/high-fructose diet renders the liver incapable of net hepatic glucose uptake.lld:pubmed
pubmed-article:20823448pubmed:affiliationVanderbilt Univ. School of Medicine, Nashville, TN 37232, USA. katie.colbert@vanderbilt.edulld:pubmed
pubmed-article:20823448pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20823448pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed